These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10728314)

  • 1. The context: investigation into hypertension and cardiac hypertrophy.
    Sen S
    Cardiovasc Res; 2000 Jan; 45(1):63-7. PubMed ID: 10728314
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats: an historical account and some follow-up.
    Pegram BL; Ishize S; Frohlich ED
    Cardiovasc Res; 2000 Jan; 45(1):77-81. PubMed ID: 10728316
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension.
    Korner PI; Jennings GL; Esler MD
    J Clin Hypertens; 1987 Sep; 3(3):341-8. PubMed ID: 2959758
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 5. Peter Meredith.
    Elliott HL; Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2016; 25(2):129-30. PubMed ID: 26873622
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of antihypertensive drugs from a historical perspective.
    van Zwieten PA; Farsang C
    Blood Press; 2005; 14(2):72-9. PubMed ID: 16036483
    [No Abstract]   [Full Text] [Related]  

  • 8. A brief history of hypertension.
    Johns Hopkins Med Lett Health After 50; 1999 Aug; 11(6):7. PubMed ID: 10453714
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemplating the history of drug therapy for hypertension.
    Rosenthal T
    Blood Press; 2004; 13(5):262-71. PubMed ID: 15545148
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of antihypertensive therapy in the 20th century.
    Piepho RW; Beal J
    J Clin Pharmacol; 2000 Sep; 40(9):967-77. PubMed ID: 10975068
    [No Abstract]   [Full Text] [Related]  

  • 11. Basis and clinical significance of regression of hypertensive hypertrophy.
    Motz W; Zähringer J; Strauer BE
    Basic Res Cardiol; 1986; 81 Suppl 1():171-8. PubMed ID: 2947563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [History of the treatment of essential hypertension--part II].
    Widimský J
    Vnitr Lek; 2002 Feb; 48(2):161-70. PubMed ID: 11949227
    [No Abstract]   [Full Text] [Related]  

  • 13. History of fixed-dose combination therapy for hypertension.
    Wofford JL
    Arch Intern Med; 1997 May; 157(9):1044. PubMed ID: 9140279
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.
    Pfeffer MA; McMurray JJ
    N Engl J Med; 2016 Nov; 375(18):1756-1766. PubMed ID: 27806228
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitroprusside and the treatment of hypertension.
    Ventura HO
    Congest Heart Fail; 2011; 17(1):49. PubMed ID: 21272230
    [No Abstract]   [Full Text] [Related]  

  • 16. Milestones in clinical pharmacology. Therapy for hypertension.
    Farrar GE
    Clin Ther; 1991; 13(5):656-8. PubMed ID: 1799923
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension: a turning point in the history of medicine...and mankind.
    Hamdy RC
    South Med J; 2001 Nov; 94(11):1045-7. PubMed ID: 11780670
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of left cardiac hypertrophy in arterial hypertension].
    Riegger AJ
    Dtsch Med Wochenschr; 1986 Sep; 111(38):1448-9. PubMed ID: 2944734
    [No Abstract]   [Full Text] [Related]  

  • 19. John H. Laragh, MD: clinician-scientist.
    Sealey JE
    Am J Hypertens; 2014 Aug; 27(8):1019-23. PubMed ID: 25103936
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.